The Link between Modifiable Risk Factors and Myeloid Disorders—From Plate to Pathogenesis

Myeloid disorders are associated with inflammation and metabolic disorders such as obesity and diabetes mellitus. Dietary and lifestyle modifications may directly influence the pathogenesis, development, and survival by addressing inflammatory and metabolic pathways. However, additional preclinical research and large prospective clinical trials are needed to confirm these findings. This review provides an overview on myeloid disorder pathogenesis and modifiable factors that influence it, which may guide future research to reduce the myeloid disorder burden and improve outcomes for patients with clonal hematopoiesis of indeterminate potential, myelodysplastic syndromes, and acute myeloid leukemia.

Authors

Institutions

Publication Details

Journal
Blood Cancer Discovery
Published
2025-11-12
DOI
https://doi.org/10.1158/2643-3230.bcd-25-0056
Citations
1
Primary Topic
Acute Myeloid Leukemia Research
Type
article
Field-Weighted Citation Impact
1.77
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Link between Modifiable Risk Factors and Myeloid Disorders—From Plate to Pathogenesis

Urvi Ashok Shah, Joshua T. Weinreb, Omar Abdel‐Wahab
1 citations
Blood Cancer Discovery
Acute Myeloid Leukemia Research
1.77
article

The Link between Modifiable Risk Factors and Myeloid Disorders—From Plate to Pathogenesis

Urvi Ashok Shah, Joshua T. Weinreb, Omar Abdel‐Wahab
article en
1 citations

Abstract

Myeloid disorders are associated with inflammation and metabolic disorders such as obesity and diabetes mellitus. Dietary and lifestyle modifications may directly influence the pathogenesis, development, and survival by addressing inflammatory and metabolic pathways. However, additional preclinical research and large prospective clinical trials are needed to confirm these findings. This review provides an overview on myeloid disorder pathogenesis and modifiable factors that influence it, which may guide future research to reduce the myeloid disorder burden and improve outcomes for patients with clonal hematopoiesis of indeterminate potential, myelodysplastic syndromes, and acute myeloid leukemia.

Blood Cancer DiscoveryVol. 7(1)
Memorial Sloan Kettering Cancer Center (US)
Openalex Percentile: Top 11%
Acute Myeloid Leukemia Research
1.77
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.